Heparin-like polymers modulate proinflammatory cytokine production by lipopolysaccharide-stimulated human monocytes

被引:22
作者
Anastase-Ravion, S
Carreno, MP
Blondin, C
Ravion, O
Champion, J
Chaubet, F
Haeffner-Cavaillon, N
Letourneur, D [1 ]
机构
[1] X Bichat Med Sch, INSERM, ERIT M, F-75018 Paris, France
[2] Univ Paris 13, Inst Galilee, LRM, F-93430 Villetaneuse, France
[3] Hop Broussais, INSERM, U430, F-75014 Paris, France
来源
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH | 2002年 / 60卷 / 03期
关键词
cytokine; heparin-like; interleukin; lipopolysaccharide; monocytes;
D O I
10.1002/jbm.10112
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The search for heparin-like materials remains an intensive field of research. In this context, we studied the immunomodulatory properties of semisynthetic dextran derivatives and naturally occurring sulfated polysaccharides present in brown seaweed (fucans). In this study, we investigated the functional potencies of fucan and dextran derivatives by analyzing their effects on the release of proinflammatory cytokines by resting or lipopolysaccharide (LPS)stimulated human monocytes and their interactions on monocyte surfaces. The results showed that fucan, dextran derivatives, and heparin differentially (1) triggered interleukin-let, tumor necrosis factor alpha, interleukin-6, and interleukin-8 production by monocytes in a dose-dependent manner, (2) modulated cytokine production by LPS-stimulated monocytes, and (3) specifically inhibited the binding of biotinylated LPS to monocyte membranes. Taken together, these data indicated that fucan and dextran derivatives displayed interesting immunomodulatory effects on human blood cells that could be relevant as new drugs or biomaterial coatings. Indeed, such polysaccharides, by regulating monocyte activation, could contribute to the improved biocompatibility of implants. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 55 条
[1]   EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].
ABRAHAM, E ;
WUNDERINK, R ;
SILVERMAN, H ;
PERL, TM ;
NASRAWAY, S ;
LEVY, H ;
BONE, R ;
WENZEL, RP ;
BALK, R ;
ALLRED, R ;
PENNINGTON, JE ;
WHERRY, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941
[2]  
ANASTASERAVION S, 1999, THESIS U PARIS 13 PA
[3]  
ANDERSON JM, 1988, ASAIO, V11, P101
[4]  
Attanasio M, 1998, THROMB HAEMOSTASIS, V79, P959
[5]  
Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.3.CO
[6]  
2-4
[7]   Relationships between chemical characteristics and anticomplementary activity of fucans [J].
Blondin, C ;
Chaubet, F ;
Nardella, A ;
Sinquin, C ;
Jozefonvicz, J .
BIOMATERIALS, 1996, 17 (06) :597-603
[8]  
Carr S, 1999, Biomed Sci Instrum, V35, P211
[9]  
Cavaillon JM, 1996, J ENDOTOXIN RES, V3, P471, DOI 10.1177/096805199600300605
[10]  
CAVAILLON JM, 1992, BACTERIAL ENDOTOXIC